Phase
Condition
Diabetic Retinopathy
Macular Edema
Diabetic Macular Edema
Treatment
Dexamethasone ophthalmic suspension (OCS-01)
Vehicle
Clinical Study ID
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria (selection):
Have a signed informed consent form before any study-specific procedures are performed.
Have DME with presence of intraretinal and/or subretinal fluid in the study eye, with CST of ≥310 µm by SD-OCT at screening (Visit 1) (as assessed by an independent reading center).
Have a documented diagnosis of Type 1 or Type 2 diabetes mellitus prior to screening (Visit 1).
Exclusion Criteria (selection):
Have macular edema considered to be because of a cause other than DME.
Have a decrease in BCVA because of causes other than DME.
Have a known history of significant macular ischemia which would prevent gain in visual acuity in the study eye.
Study Design
Study Description
Connect with a study center
Oculis Investigative Site - Stanford Byers Eye Institute
Palo Alto, California 94303
United StatesActive - Recruiting
Oculis Investigative Site - Sierra Eye Associates
Reno, Nevada 89502
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.